LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Combined DNA Technologies Analyzed for Malaria Diagnosis

By LabMedica International staff writers
Posted on 08 Nov 2018
Print article
Image: The Loopamp Malaria Pan Detection Kit is a qualitative test for detection of Malaria Pan species (Plasmodium ovale, P. vivax, P. malariae and P. falciparum) in human blood samples (Photo courtesy of Human Diagnostics Worldwide).
Image: The Loopamp Malaria Pan Detection Kit is a qualitative test for detection of Malaria Pan species (Plasmodium ovale, P. vivax, P. malariae and P. falciparum) in human blood samples (Photo courtesy of Human Diagnostics Worldwide).
Malaria is one of the most important parasitic infectious diseases for which almost half of the world’s population is at risk. Although several diagnostic methods are now available to detect the infection, more sensitive and applicable tests are still required in the field.

The loop-mediated isothermal amplification (LAMP) method is a DNA amplification tool in which the DNA amplification can be achieved by incubation at a stable temperature. In parallel, a simple DNA extraction method, the procedure for ultra-rapid extraction (PURE), which can produce a DNA solution suitable for the LAMP reaction without the use of a centrifuge, has also become available.

Scientists at the University of Tsukuba (Ibaraki, Japan) and their colleagues used a nested polymerase chain reaction (PCR) as the reference, and tested 117 samples including 46 Plasmodium falciparum, seven P. vivax, nine P. ovale, four P. malariae, and 51 negative cases. The microscopic diagnosis was conducted by expert microscopists on light microscopes with Giemsa-stained thin blood smears. Rapid diagnostic tests (RDT were conducted using BinaxNow Malaria. DNA was extracted using the Loopamp PURE DNA Extraction Kit and the LAMP reactions were performed with the Loopamp MALARIA Pan/Pf Detection Kit.

The team reported that the PURE–LAMP Pan correctly identified 64 of the 66 positives and the 51 negatives. Among the Pan-positive samples 45 P. falciparum were also detected with the PURE–LAMP Pf. The PURE–LAMP Pan and PURE–LAMP Pf had respective sensitivities of 96.96% and 97.82% and common specificity of 1. All negatives by PURE–LAMP were also negative by microscopy. Only two positive samples by PURE–LAMP [Pan(+)Pf(+)], which were in conformity with the P. falciparum diagnosis by the nested PCR, were misdiagnosed by microscopy as negative.

The authors concluded that filter paper is already a well-known field support method as it allows the collection, transfer, and storage of samples without a cold chamber. Considering the designed-in field-friendliness of this PURE–LAMP combination method, use of this system with dried blood samples will allow maximum exploitation of this characteristic while still performing accurately. The PURE–LAMP system is accurate when used with dried blood spots and extendable to the field. The study was published on October 22, 2018, in the Malaria Journal.

Related Links:
University of Tsukuba

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Respiratory QC Panel
Assayed Respiratory Control Panel

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.